NERV
Minerva NeurosciencesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
NERV vs peer average
87/100
NERV vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANTX is the first available peer comparator.
Small‑cap clinical biotech with similar market cap, reliance on pivotal readouts, and comparable balance‑sheet sensitivity to financing timing.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NERV
Minerva Neurosciences
ANTX
AN2 Therapeutics
Grade
A
B
Momentum
86
99
Value
42
41
Sentiment
66
42
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ANTX
NERV / ANTX
Grade Position
Above peers
NERV vs. peer average (A vs. C)
87/100
Momentum
86
ANTXValue
42
NERVSentiment
66
NERVRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NERV
ANTX is the first peer returned for this comparison set.